Cargando…

Safety and Efficacy of Daratumumab in Patients with Proliferative GN with Monoclonal Immunoglobulin Deposits

BACKGROUND: Treatment of proliferative GN with monoclonal Ig deposits (PGNMID) is not established. A monoclonal anti-CD38 antibody (daratumumab) is effective in treating multiple myeloma. Abnormal plasma cell clones may play a role in the pathogenesis of PGNMID. METHODS: We evaluated daratumumab’s s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zand, Ladan, Rajkumar, S. Vincent, Leung, Nelson, Sethi, Sanjeev, El Ters, Mireille, Fervenza, Fernando C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Nephrology 2021
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8259683/ https://www.ncbi.nlm.nih.gov/pubmed/33685975 http://dx.doi.org/10.1681/ASN.2020101541

Ejemplares similares

Daratumumab in Patients With Bortezomib-Refractory Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits
por: Almaani, Salem, et al.
Publicado: (2021)

Relapsing and Remitting Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits in Association With Infection and Vaccination: A Case Report
por: Moubarak, Simon, et al.
Publicado: (2022)

PLEX in AAV-GN: insights from the meta-analysis results and impact on remission induction treatment recommendations
por: Casal Moura, Marta, et al.
Publicado: (2022)

An update of proliferative glomerulonephritis with monoclonal immunoglobulin deposits
por: Li, Manna, et al.
Publicado: (2021)

A Review on the Diagnosis and Treatment of Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits
por: Lin, Li, et al.
Publicado: (2022)

Proliferative glomerulonephritis with monoclonal immunoglobulin deposition disease: The utility of routine staining with immunoglobulin light chains
por: Gowda, K. K., et al.
Publicado: (2015)

Clinical and pathological phenotype of genetic causes of focal segmental glomerulosclerosis in adults
por: Lepori, Nicola, et al.
Publicado: (2018)

Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: Successful treatment for new and rare entity
por: Jerbi, Mouna, et al.
Publicado: (2020)

Efficacy of Immunomodulatory Drugs in Combination With Dexamethasone in Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits
por: Zhou, Houan, et al.
Publicado: (2022)

Focal and segmental glomerulosclerosis: clinical and kidney biopsy correlations
por: Sethi, Sanjeev, et al.
Publicado: (2014)

Nephrotic Syndrome Secondary to Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits of Lambda Light Chain
por: Yun, Seongseok, et al.
Publicado: (2014)

Proliferative Glomerulonephritis with Monoclonal Immunoglobulin G Lambda Deposits: Report of the First Pediatric Case
por: Torrealba, Jose, et al.
Publicado: (2018)

Proliferative glomerulonephritis with monoclonal immunoglobulin deposits triggered by COVID-19: a case report
por: Shieh, Michelle, et al.
Publicado: (2022)

An Open-Label Pilot Study of Adrenocorticotrophic Hormone in the Treatment of IgA Nephropathy at High Risk of Progression
por: Zand, Ladan, et al.
Publicado: (2019)

Proliferative glomerulonephritis with monoclonal immunoglobulin G deposits in a young woman: A case report
por: Xu, Zi-Gan, et al.
Publicado: (2021)

Anti-CD20 should be the first-line treatment in high-risk membranous nephropathy
por: Zand, Ladan, et al.
Publicado: (2023)

Proliferative glomerulonephritis with monoclonal immunoglobulin in renal allografts
por: Al-Rabadi, Laith, et al.
Publicado: (2015)

Post-infectious Proliferative Glomerulonephritis with Monoclonal Immunoglobulin G Deposits Associated with Complement Factor H Mutation
por: Takehara, Eriko, et al.
Publicado: (2017)

Leishmaniasis-Associated Membranoproliferative Glomerulonephritis With Massive Complement Deposition
por: Sethi, Sanjeev, et al.
Publicado: (2016)

Microscopic hematuria as a risk factor for IgAN progression: considering this biomarker in selecting and monitoring patients
por: Zand, Ladan, et al.
Publicado: (2023)

Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits without Conspicuous Mesangial Proliferation, Complicated with Squamous Cell Lung Carcinoma
por: Higashihara, Takaaki, et al.
Publicado: (2019)

Proliferative Glomerulonephritis with Monoclonal Immunoglobulins in a Child with Recurrence in the Allograft
por: Madireddy, Nishika, et al.
Publicado: (2023)

Clone-directed therapy for proliferative glomerulonephritis with monoclonal immunoglobulin depositions: is it always necessary?: Two case reports and literature review
por: van Kruijsdijk, Rob C. M., et al.
Publicado: (2020)

Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumab
por: Abdallah, Nadine, et al.
Publicado: (2022)

Correction: Tracking daratumumab clearance using mass spectrometry: implications on M protein monitoring and reusing daratumumab
por: Abdallah, Nadine, et al.
Publicado: (2022)

Atypical post-infectious glomerulonephritis is associated with abnormalities in the alternative pathway of complement
por: Sethi, Sanjeev, et al.
Publicado: (2012)

Proliferative Glomerulonephritis With Masked Monoclonal Deposits Responsive to Myeloma Therapy
por: Howlader, Anjuman, et al.
Publicado: (2017)

KM55 Monoclonal Antibody and IgA Variant of Proliferative Glomerulonephritis With Monoclonal Ig Deposits
por: Zhang, Minfang, et al.
Publicado: (2020)

C3 Glomerulonephritis: Clinicopathologic findings, complement abnormalities, glomerular proteomic profile, treatment and follow-up
por: Sethi, Sanjeev, et al.
Publicado: (2012)

Renal Diseases Associated with Hematologic Malignancies and Thymoma in the Absence of Renal Monoclonal Immunoglobulin Deposits
por: Morel, Antoine, et al.
Publicado: (2021)

Membranoproliferative glomerulonephritis with masked monotypic immunoglobulin deposits
por: Larsen, Christopher P, et al.
Publicado: (2015)

Acute bilateral angle closure induced by monoclonal antibody (Daratumumab) infusion
por: Saengsirinavin, Aim-on, et al.
Publicado: (2021)

Clinicopathological manifestations of coexistent monoclonal immunoglobulin deposition disease and immunotactoid glomerulopathy
por: Wang, Yina, et al.
Publicado: (2022)

Randall-Type Monoclonal Immunoglobulin Deposition Disease: New Insights into the Pathogenesis, Diagnosis and Management
por: Cohen, Camille, et al.
Publicado: (2021)

Relapsing proliferative glomerulonephritis with monoclonal IgG deposits showing circumferential crescentic glomerulonephritis
por: Oshio, Mai, et al.
Publicado: (2013)

Proliferative glomerulonephritis associated with monoclonal immune deposits: A case report and review of literature
por: Fatima, R., et al.
Publicado: (2014)

Clinicopathological analysis of proliferative glomerulonephritis with monoclonal IgG deposits in 5 renal allografts
por: Wen, Jiqiu, et al.
Publicado: (2018)

An Exceptional Case of Light Chain Only Variant of Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits Secondary to Chronic Lymphocytic Leukemia: A Case Report and Review of the Literature
por: De La Flor, José C., et al.
Publicado: (2022)

Glomerulonephritis with non-Randall-type, non-cryoglobulinaemic monoclonal immunoglobulin G deposits (PGNMID and ITG)
por: Fourdinier, Ophélie, et al.
Publicado: (2022)

Steroid-responsive nephrotic syndrome in a patient with proliferative glomerulonephritis with monoclonal IgG deposits with pure mesangial proliferative features
por: Komatsuda, Atsushi, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_6936eb0b1dmcdeqk33rl5nseo5